NPPB and arteriosclerosis disorder: Recent studies showed that plasma biomarkers such as homocysteine (Hcy), N-terminal pro-brain natriuretic peptide (NT-proBNP), and urine albumin (microalbumin) (UAE) have involved the pathophysiological development of arteriosclerosis and could be predictors of future cardiovascular events.